Case report: Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp.

American Journal of Tropical Medicine and Hygiene

Volumn 78, Issue 4, 2008, Pages 546-551

  Kamgno, Joseph ^b   Boussinesq, Michel ^c   Labrousse, François ^d   Nkegoum, Blaise ^b   Thylefors, Björn I ^e   Mackenzie, Charles D ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b National Onchoceriasis Task Force   (Cameroon)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^d DUPUYTREN UNIVERSITY HOSPITAL   (France)

^e Mectizan Donation Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; QUININE; ANTIPARASITIC AGENT;

ADULT; ARTICLE; BLOOD SMEAR; BRAIN DISEASE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FILARIASIS; HUMAN; LABORATORY TEST; LUNG INFECTION; MALE; MALNUTRITION; PLASMODIUM; ANIMAL; CAMEROON; CHEMICALLY INDUCED DISORDER; FATALITY; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; LOA; MALARIA; MIDDLE AGED; PATHOLOGY;

LOA LOA;

ANIMALS; ANTIPARASITIC AGENTS; BRAIN DISEASES; CAMEROON; FATAL OUTCOME; HUMANS; IVERMECTIN; LOA; LOIASIS; MALARIA; MALE; MIDDLE AGED; PLASMODIUM;

EID: 45349085923     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2008.78.546     Document Type: Article

References (23)

1. Twum-Danso NAY, 2003. Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future. Filaria J 2 (Suppl 1): S7.
2. Gardon J, Gardon-Wendel N, Demanga-Ngangue, Kamgno J, Chippaux JP, Boussinesq M, 1997. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350: 18-22.
3. Boussinesq M, Gardon J, Gardon-Wendel N, Chippaux JP, 2003. Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon. Filaria J 2 (Suppl 1): S4.
4. Haselow NJ, Akame J, Evini C, Akongo S, 2003. Programmatic and communication issues in relation to serious adverse events following ivermectin treatment in areas co-endemic for onchocerciasis and loiasis. Filaria J 2 (Suppl 1): S10.
5. Mackenzie CD, Geary TG, Gerlach JA, 2003. Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients. Filaria J 2 (Suppl 1): S5.
6. Fobi G, Gardon J, Santiago M, Ngangue D, Gardon-Wendel N, Boussinesq M, 2000. Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia. Ophthalmic Epidemiol 7: 27-39.
7. Kamgno J, Boussinesq M, 2001. Hyperendémicité de la loase dans la plaine Tikar, région de savane arbustive du Cameroun. Bull Soc Pathol Exot 94: 342-346.
8. Thomson MC, Obsomer V, Kamgno J, Gardon J, Wanji S, Takougang I, Enyong P, Remme JH, Molyneux DH, Boussinesq M, 2004. Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control. Filaria J 3: 7.
9. Twum-Danso NAY, Meredith SEO, 2003. Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis. Trop Med Int Health 8: 820-831.
10. Boussinesq M, Gardon J, Gardon-Wendel N, Kamgno J, Ngoumou P, Chippaux JP, 1998. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis. Am J Trop Med Hyg 58: 461-469.
11. Chambon M, 1933. Présence de microfilaires dans le liquide céphalorachidien d'un trypanosomé avancé. Bull Soc Pathol Exot 26: 613-614.
12. Bonnet M, 1943. Réflexions sur un cas de méningite aiguë à Microfilaria loa. Med Trop (Mars) 3: 273-277.
13. Kivits M, 1952. Quatre cas d'encéphalite mortelle avec invasion du liquide céphalo-rachidien par Microfilaria loa. Ann Soc Belg Med Trop 32: 235-242.
14. Cattan R, Frumusan P, Levy C, 1960. Encéphalopathie filarienne. Bull Mem Soc Med Hop Paris 76: 808-810.
15. Cauchie C, Rutsaert J, Thys O, Bonnyns M, Perrier O, 1965. Encéphalite à Loa-loa, traitée par l'association de cortisone et de carbamazine. Rev Belg Pathol Med Exp 31: 232-244.
16. Same-Ekobo A, Same-Voisin C, Eben-Moussi E, Ongmagne MJ, 1981. A propos d'un cas de méningo-encéphalite filarienne à Loa loa. Rappels des critères de diagnostic de certitude. Afr Med 20: 359-361.
17. Lukiana T, Mandina M, Situakibanza NH, Mbula MM, Lepira BF, Odio WT, Kamgno J, Boussinesq M, 2006. A possible case of spontaneous Loa loa encephalopathy associated with a glomerulopathy. Filaria J 5: 6.
18. Didier A, Loor F, 1996. The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor. Anticancer Drugs 7: 745-751.
19. Lovell RA, 1990. Ivermectin and piperazine toxicoses in dogs and cats. Vet Clin North Am Small Anim Prac 20: 453-468.
20. Chung K, Yang CC, Wu ML, Deng JF, Tsai WJ, 1999. Agricultural avermectins: an uncommon but potentially fatal cause of pesticide poisoning. Ann Emerg Med 34: 51-57.
21. Van Bogaert L, Dubois A, Janssens PG, Radermecker J, Tverdy G, Wanson M, 1955. Encephalitis in Loa-loa filariasis. J Neurol Neurosurg Psychiat 18: 103-119.
22. Negesse Y, Lanoie LO, Neafie RC, Connor DH, 1985. Loiasis: "Calabar" swellings and involvement of deep organs. Am J Trop Med Hyg 34: 537-546.
23. Mackenzie CD, Geary TG, Pritchard R, Boussinesq M, 2007. Where next with Loa loa encephalopathy? Data are badly needed. Trends Parasitol 23: 237-238.